Items where Subject is "Department of Haematology"
- UCL Eprints (16692)
- UCL Departments and Research Centres (8563)
- UCL Biomedical Sciences (1510)
- Department of Haematology (31)
- UCL Biomedical Sciences (1510)
- UCL Departments and Research Centres (8563)
Number of items at this level: 31.
A
Ahmed, F;
Ings, SJ;
Pizzey, AR;
Blundell, MP;
Thrasher, AJ;
Ye, HT;
Fahey, A;
... Yong, KL; + view all
(2004)
Impaired bone marrow homing of cytokine-activated CD34<sup>+</sup> cells in the NOD/SCID model.
Blood
, 103
(6)
pp. 2079-2087.
10.1182/blood-2003-06-1770.
|
 |
|
Ancliff, PJ;
Gale, RE;
Watts, MJ;
Liesner, R;
Hann, IM;
Strobel, S;
Linch, DC;
(2002)
Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia.
Blood
, 100
(2)
pp. 707-709.
10.1182/blood-2002-01-0060.
|
|
C
|
Chakrabarti, S.;
Mackinnon, S.;
Chopra, R.;
Kottaridis, P.D.;
Peggs, K.;
O'Gorman, P.;
Chakraverty, R.;
... Milligan, D.W.; + view all
(2002)
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.
Blood
, 99
(12)
pp. 4357-4363.
10.1182/blood.V99.12.4357.
|
|
|
Chakraverty, R;
Cote, D;
Buchli, J;
Cotter, P;
Hsu, R;
Zhao, GL;
Sachs, T;
... Sykes, M; + view all
(2006)
An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues.
J EXP MED
, 203
(8)
2021 - 2031.
10.1084/jem.20060376.
|
|
|
Clark, RE;
Dodi, IA;
Hill, SC;
Lill, JR;
Aubert, G;
Macintyre, AR;
Rojas, J;
... Madrigal, JA; + view all
(2001)
Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein.
Blood
, 98
(10)
pp. 2887-2893.
|
|
D
|
Davidoff, AM;
Ng, CYC;
Zhou, J;
Spence, Y;
Nathwani, AC;
(2003)
Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway.
Blood
, 102
(2)
pp. 480-488.
10.1182/blood-2002-09-2889.
|
|
|
Dotti, G;
Savoldo, B;
Pule, M;
Straathof, KC;
Biagi, E;
Yvon, E;
Vigouroux, S;
... Rooney, CM; + view all
(2005)
lHuman cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.
BLOOD
, 105
(12)
4677 - 4684.
10.1182/blood-2004-08-3337.
|
|
E
|
Everington, T.;
(2009)
Investigation of the molecular and functional pathophysiology of polycythaemia vera.
Doctoral thesis , UCL (University College London).
|
G
|
Gale, RE;
Hills, R;
Kottaridis, PD;
Srirangan, S;
Wheatley, K;
Burnett, AK;
Linch, DC;
(2005)
No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML 10 and 12 trials.
BLOOD
, 106
(10)
3658 - 3665.
10.1182/blood-2005-03-1323.
|
|
|
Gale, RE;
Hills, R;
Pizzey, AR;
Kottaridis, PD;
Swirsky, D;
Gilkes, AF;
Nugent, E;
... NCRI Adult Leukaemia Working Party; + view all
(2005)
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.
BLOOD
, 106
(12)
3768 - 3776.
|
|
H
|
Harrison, C.N.;
Donohoe, S.;
Carr, P.;
Dave, M.;
Mackie, I.;
Machin, S.J.;
(2002)
Patients with Essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis.
Thrombosis and haemostasis
, 87
(5)
pp. 802-807.
|
|
|
Huntly, BJP;
Reid, AG;
Bench, AJ;
Campbell, LJ;
Telford, N;
Shepherd, P;
Szer, J;
... Green, AR; + view all
(2001)
Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia.
BLOOD
, 98
(6)
1732 - 1738.
|
|
J
|
Jakupovic, I.;
Grandage, V.L.;
Linch, D.C.;
Khwaja, A.;
(2004)
Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells.
Blood
, 103
(8)
pp. 3230-3232.
10.1182/blood-2003-06-1985.
|
|
|
Jones, DT;
Ganeshaguru, K;
Virchis, AE;
Folarin, NI;
Lowdell, MW;
Mehta, AB;
Prentice, HG;
... Wickremasinghe, RG; + view all
(2001)
Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation.
Blood
, 98
(9)
pp. 2800-2807.
10.1182/blood.v98.9.2800.
|
|
|
Jones, DT;
Addison, E;
North, JM;
Lowdell, MW;
Hoffbrand, AV;
Mehta, AB;
Ganeshaguru, K;
... Wickremasinghe, RG; + view all
(2004)
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs.
Blood
, 103
(5)
pp. 1855-1861.
10.1182/blood-2003-05-1603.
|
|
|
Jones, DT;
Ganeshaguru, K;
Anderson, RJ;
Jackson, TR;
Bruckdorfer, KR;
Low, SY;
Palmqvist, L;
... Wickremasinghe, RG; + view all
(2002)
Albumin activates the AKT signalling pathway and protects B-chronics lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis.
Blood
10.1182/blood-2002-07-2143.
|
|
K
|
Kottaridis, P.D.;
Gale, R.E.;
Frew, M.E.;
Harrison, G.;
Langabeer, S.E.;
Belton, A.A;
Walker, H.;
... Linch, D.C.; + view all
(2001)
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.
Blood
, 98
(6)
pp. 1752-1759.
10.1182/blood.V98.6.1752.
|
|
|
Kottaridis, P.D.;
Gale, R.E.;
Langabeer, S.E.;
Frew, M.E.;
Bowen, D.T.;
Linch, D.C.;
(2002)
Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors.
Blood
, 100
(7)
pp. 2393-2398.
10.1182/blood-2002-02-0420.
|
|
L
|
Lawrence, KM;
Chanalaris, A;
Scarabelli, T;
Hubank, M;
Pasini, E;
Townsend, PA;
Comini, L;
... Latchman, DS; + view all
(2002)
K-ATP channel gene expression is induced by urocortin and mediates its cardioprotective effect.
CIRCULATION
, 106
(12)
1556 - 1562.
10.1161/01.CIR.0000028424.02525.AE.
|
|
M
|
Mainwaring, P.N.;
Cunningham, D.;
Gregory, W.;
Hoskin, P.;
Hancock, B.;
Norton, A.J.;
MacLennan, K.;
... Linch, D.; + view all
(2001)
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.
Blood
, 97
(10)
pp. 2991-2997.
10.1182/blood.V97.10.2991.
|
|
|
Mead, A.J.;
(2009)
The clinical and biological consequences of different FLT3 mutations in patients with AML.
Doctoral thesis , UCL (University College London).
|
|
|
Morris, E.;
Thomson, K.;
Craddock, C.;
Mahendra, P.;
Milligan, D.;
Cook, G.;
Smith, G.M.;
... Mackinnon, S.; + view all
(2004)
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma.
Blood
, 104
(13)
pp. 3865-3871.
10.1182/blood-2004-03-1105.
|
|
N
|
Nathwani, AC;
Davidoff, A;
Hanawa, H;
Zhou, JF;
Vanin, EF;
Nienhuis, AW;
(2001)
Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.
Blood
, 97
(5)
pp. 1258-1265.
10.1182/blood.v97.5.1258.
|
|
P
|
Paterson, PJ;
Seaton, S;
McHugh, TD;
McLaughlin, J;
Potter, M;
Prentice, HG;
Kibbler, CC;
(2006)
Validation and clinical application of molecular methods for the identification of molds in tissue.
CLIN INFECT DIS
, 42
(1)
51 - 56.
|
|
|
Peggs, K;
Verfuerth, S;
Pizzey, A;
Ainsworth, J;
Moss, P;
Mackinnon, S;
(2002)
Characterization of human cytomegalovirus peptide-specific CD8<sup>+</sup> T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells.
Blood
, 99
(1)
pp. 213-223.
10.1182/blood.V99.1.213.
|
|
|
Peggs, K.S.;
Thomson, K.;
Hart, D.P.;
Geary, J.;
Morris, E.C.;
Yong, K.;
Goldstone, A.H.;
... Mackinnon, S.; + view all
(2003)
Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.
Blood
, 103
(4)
pp. 1548-1556.
10.1182/blood-2003-05-1513.
|
 |
Q
|
Quezada, SA;
Peggs, KS;
Curran, MA;
Allison, JP;
(2006)
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.
J CLIN INVEST
, 116
(7)
1935 - 1945.
10.1172/JCI27745.
|
|
R
|
Robinson, J.;
Waller, M.J.;
Stoehr, P.;
Marsh, S.G.E.;
(2005)
IPD - the Immuno Polymorphism Database.
Nucleic Acids Research
, 33
(Databa)
D523-D526.
10.1093/nar/gki032.
|
|
|
Rowe, J.M.;
Buck, G.;
Burnett, A.K.;
Chopra, R.;
Wiernik, P.H.;
Richards, S.M.;
Lazarus, H.M.;
... Goldstone, A.H.; + view all
(2005)
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.
Blood
, 106
(12)
pp. 3760-3767.
10.1182/blood-2005-04-1623.
|
|
S
|
Shaw, BE;
Marsh, SGE;
Mayor, NP;
Russell, NH;
Madrigal, JA;
(2006)
HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants.
Blood
, 107
(3)
pp. 1220-1226.
10.1182/blood-2005-08-3121.
|
|
|
Straathof, KC;
Pule, MA;
Yotnda, P;
Dotti, G;
Vanin, EF;
Brenner, MK;
Heslop, HE;
... Rooney, CM; + view all
(2005)
An inducible caspase 9 safety switch for T-cell therapy.
BLOOD
, 105
(11)
pp. 4247-4254.
10.1182/blood-2004-11-4564.
|
|
